Boothbay Fund Management, LLC Kala Pharmaceuticals, Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$6.24 - $9.58 $62,992 - $96,710	-10,095 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$6.28 - $8.79 $262,516 - $367,439	-41,802 Reduced 80.55%	10,095 $68,000
Q3 2020 Nov 16, 2020	BUY	$7.5 - $11.11 $389,227 - $576,575	51,897 New	51,897 $389,000
Q2 2020 Aug 14, 2020	SELL	$8.33 - $13.79 $677,029 - $1.12 Million	-81,276 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$3.83 - $8.79 $334,929 - $768,676	-87,449 Reduced 51.83%	81,276 $714,000
Q3 2019 Nov 14, 2019	BUY	$3.57 - $6.58 $602,348 - $1.11 Million	168,725 New	168,725 $642,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $7.69M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.